AnticoagEvaluator
AnticoagEvaluator generates an estimated $0/month in revenue from 2–6 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-06-19).
| Est. revenue / month | $0 |
|---|---|
| Est. downloads / month | 2–6 |
| Estimate confidence | medium |
| Pricing | Free |
| Rating | 2.33 ★ (3 ratings) |
| Category | Medical |
| Released | 06.03.2013 |
| App last updated | 21.11.2024 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · medium confidence
About
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 5Ratings & velocity
Rating distribution
33% positive · 3 ratingsGeographic reach
best rank · 0 storefrontsRevenue & downloads trend
ARPU $0Update history
1 update tracked- v5.0.0.71.6y ago
This app has been updated with an enhanced Risk Bar which showcases CHA2DS2-VASc and ATRIA stroke risk point scores for all patients alongside the stroke risk magnitude percentage. In addition, a visual display bug was fixed and standard notification functionality was incorporated.
AnticoagEvaluator — FAQ
How many downloads does AnticoagEvaluator get?
AnticoagEvaluator sees an estimated 2–6 downloads per month on the App Store, per AppCurrents modeling.
Is AnticoagEvaluator free?
AnticoagEvaluator is free to download on the App Store, with no in-app purchases detected.
What is AnticoagEvaluator's rating?
AnticoagEvaluator holds a 2.33-star average from 3 ratings on the App Store.
When was AnticoagEvaluator released?
AnticoagEvaluator launched on the App Store on 06.03.2013. Its latest version shipped 21.11.2024.
